Literature DB >> 18460349

Regulation of apoptosis-related genes by nitric oxide in cancer.

Samuel Y Olson1, Hermes J Garbán.   

Abstract

Nitric oxide (NO) is a simple molecule with a complex and pleiotropic biological activity. NO or related species have been implicated in the regulation of many genes that participate in many diverse biological functions including programmed cell death or apoptosis. Apoptosis is a process that may potentially be disrupted in cancer cells conferring a survival advantage. In addition, malignant tumor cells can develop an intricate system of resistance to apoptotic stimuli. NO or related species have been shown to play a dual role in the regulation of apoptosis in malignant cells either promoting cell death or protecting cells from pro-apoptotic induction. However, the specific role of NO in the regulation of apoptosis/survival-related genes expression seems to tilt the balance toward the promotion of pro-apoptotic and the suppression of anti-apoptotic genes. Herein we have reviewed the most relevant aspects involving NO and/or reactive intermediates in the regulation of apoptosis-related genes--mainly--at the transcriptional level. We described the basic apoptotic molecules that potentially are affected by NO and how NO-mediated signaling gets transmitted to the transcriptional machinery that governs the expression of these genes. In addition, we discussed some of the fundamental functional consequences of the regulation of apoptosis-related genes by NO in cancer biology and its potential therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460349      PMCID: PMC2536640          DOI: 10.1016/j.niox.2008.04.005

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  101 in total

1.  Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172.

Authors:  A Hokari; M Zeniya; H Esumi
Journal:  J Biochem       Date:  1994-09       Impact factor: 3.387

Review 2.  Apoptosis and cancer: the failure of controls on cell death and cell survival.

Authors:  S J Martin; D R Green
Journal:  Crit Rev Oncol Hematol       Date:  1995-02       Impact factor: 6.312

Review 3.  Apoptosis in the pathogenesis and treatment of disease.

Authors:  C B Thompson
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

4.  Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level.

Authors:  P J Andrew; H Harant; I J Lindley
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575

5.  Roles of nitric oxide in tumor growth.

Authors:  D C Jenkins; I G Charles; L L Thomsen; D W Moss; L S Holmes; S A Baylis; P Rhodes; K Westmore; P C Emson; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

Authors:  H B Peng; P Libby; J K Liao
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

Review 7.  S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups.

Authors:  J S Stamler
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 8.  Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas.

Authors:  H J Gruss; S K Dower
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

9.  Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells.

Authors:  H B Peng; T B Rajavashisth; P Libby; J K Liao
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

10.  The high-output nitric oxide pathway: role and regulation.

Authors:  Q Xie; C Nathan
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

View more
  11 in total

1.  The extreme anterior domain is an essential craniofacial organizer acting through Kinin-Kallikrein signaling.

Authors:  Laura Jacox; Radek Sindelka; Justin Chen; Alyssa Rothman; Amanda Dickinson; Hazel Sive
Journal:  Cell Rep       Date:  2014-07-17       Impact factor: 9.423

2.  Microarray-based Analysis of Genes, Transcription Factors, and Epigenetic Modifications in Lung Cancer Exposed to Nitric Oxide.

Authors:  Arnatchai Maiuthed; Ornjira Prakhongcheep; Pithi Chanvorachote
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

3.  Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.

Authors:  Ying Wai Lam; Yong Yuan; Jared Isaac; C V Suresh Babu; Jarek Meller; Shuk-Mei Ho
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

4.  Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genes.

Authors:  Rong Wang; Andrew Freywald; Yue Chen; Jianqing Xu; Xin Tan; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

Review 5.  Nitric oxide in cancer metastasis.

Authors:  Huiwen Cheng; Lei Wang; Molly Mollica; Anthony T Re; Shiyong Wu; Li Zuo
Journal:  Cancer Lett       Date:  2014-07-29       Impact factor: 8.679

6.  Mutation of a putative S-nitrosylation site of TRPV4 protein facilitates the channel activates.

Authors:  Eun Jeoung Lee; Sung Hwa Shin; Sunghee Hyun; Jaesun Chun; Sang Sun Kang
Journal:  Anim Cells Syst (Seoul)       Date:  2011-06-09       Impact factor: 1.815

7.  Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells.

Authors:  Hui-Chin Wen; Chih-Pin Chuu; Chen-Yu Chen; Shine-Gwo Shiah; Hsing-Jien Kung; Kuang-Liang King; Liang-Chen Su; Shi-Chuan Chang; Chung-Ho Chang
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

8.  Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.

Authors:  Ornella Fantappiè; Chiara Sassoli; Alessia Tani; Daniele Nosi; Serena Marchetti; Lucia Formigli; Roberto Mazzanti
Journal:  J Cell Mol Med       Date:  2015-02-18       Impact factor: 5.310

9.  L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.

Authors:  Yu Cao; Yonghui Feng; Yanjun Zhang; Xiaotong Zhu; Feng Jin
Journal:  BMC Cancer       Date:  2016-06-01       Impact factor: 4.430

Review 10.  The Role of Nitric Oxide in Cancer: Master Regulator or NOt?

Authors:  Faizan H Khan; Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Katrina M Miranda; Sharon A Glynn
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.